| Patents for C07G 11 - Antibiotics (852) |
|---|
| 09/04/2008 | WO2008105516A1 Antifungal substance |
| 09/02/2008 | US7419657 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines |
| 08/28/2008 | WO2008103751A2 Antimicrobial and anti-inflammatory therapies and compositions |
| 08/28/2008 | US20080207538 Enhanced Production of Functional Proteins From Defective Genes |
| 08/26/2008 | US7417031 Induction apoptosis; oxidation resistance; preservatives |
| 08/06/2008 | EP1951740A2 High affinity siglec ligands |
| 08/06/2008 | CN101237771A Multidrug resistant anticancer anthracyclines |
| 08/05/2008 | US7407654 From fermentation of Streptomyces; bactericides |
| 06/24/2008 | US7390782 Methods and products related to metabolic interactions in disease |
| 05/21/2008 | EP1165751B1 A strain of bacillus pumilus for controlling plant diseases |
| 05/06/2008 | US7368431 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon |
| 04/30/2008 | EP1915180A2 Compositions and methods for treating gram positive bacterial infection in a mammalian subject |
| 04/22/2008 | US7361744 Oligosaccharide derivative |
| 03/26/2008 | EP1448784B1 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
| 02/21/2008 | US20080044860 Polyketides and Their Synthesis |
| 01/24/2008 | WO2008010776A1 Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection |
| 01/10/2008 | DE102006031151A1 Fluortenside Fluorosurfactants |
| 12/27/2007 | WO2006033024A3 Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds |
| 12/05/2007 | CN101084318A Antibacterial substance dm0507 and utilization of the same |
| 11/22/2007 | WO2007056525A3 High affinity siglec ligands |
| 10/17/2007 | EP1844331A1 Non-continuous immunoassay device and immunoassay method using the same |
| 09/20/2007 | WO2007022082A3 Vector delivery-based microbicides |
| 08/29/2007 | CN101024662A Method for purifying Ramoplanin |
| 08/29/2007 | CN101024661A Three single-component separation methods for Ramoplanin |
| 08/21/2007 | US7259141 prepared via chemoenzymatic techniques; contain a 1,2,3-triazole moeity attached to the sugar group; glycosylating a vancomycin aglycone with a sugar transferase, then reacting with an alkyne via a 1,3-dipolar cycloaddition; treating vancomycin resistant infections |
| 08/15/2007 | EP1817016A2 Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds |
| 08/01/2007 | EP1565754B1 New uses of proteins encoded by ble genes and antibiotics from the bleomycin family |
| 06/26/2007 | US7235533 Compounds and their uses |
| 06/19/2007 | US7232805 Cobalamin conjugates for anti-tumor therapy |
| 05/10/2007 | WO2007052356A1 Antibacterial substance dm0507 and utilization of the same |
| 05/01/2007 | US7211653 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 03/08/2007 | WO2006093933A3 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 02/21/2007 | CN1301134C Novel immune effect compound |
| 02/14/2007 | EP1044983B1 Antibiotic tkr2999, process for the preparation thereof and microbe |
| 01/18/2007 | WO2006124720B1 Multidrug resistant anticancer anthracyclines |
| 11/23/2006 | WO2006124720A1 Multidrug resistant anticancer anthracyclines |
| 11/23/2006 | WO2006096500A3 Highly efficient synthesis of alpha-o-galactosyl ceramides |
| 10/31/2006 | US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group |
| 10/19/2006 | US20060234954 Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides |
| 10/17/2006 | US7122526 Topoisomerase I inhibitors; such as 2,3-methylenedioxy-6-hydroxymethyl-9-hydroxy-12-(beta-D-glucopyranosyl) -6,7,12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione |
| 09/19/2006 | US7108871 Isoflavones and saponins in defined ratios, menopause, cancer |
| 09/08/2006 | CA2599336A1 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 08/22/2006 | US7094764 Substituted benzimidazole-, Benztriazole-, and benzimidazolone-O-glucosides |
| 08/15/2006 | US7090840 Lactobacillus paracasei subsp. paracasei strain antibacterial against Helicobacter pylori and Escherichia coli 0157:h7 |
| 08/10/2006 | WO2006083053A1 Non-continuous immunoassay device and immunoassay method using the same |
| 07/27/2006 | WO2005081904A3 Antimicrobial carbohydrates and methods of using same |
| 07/19/2006 | EP1679966A2 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 06/20/2006 | US7063976 Process for preparing beta-fructofuranosidase enzyme and a process for producing fructooligosaccharides |
| 11/24/2005 | WO2005086768A3 Enhanced production of functional proteins from defective genes |
| 11/23/2005 | EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition |
| 11/17/2005 | WO2005012242A3 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 10/12/2005 | CN1222610C Novel lactobacillus paracasei subsp. paracasei strain antibacterial against nelicobacter pylori and escherichia coli 157:H7 |
| 09/22/2005 | WO2005086768A2 Enhanced production of functional proteins from defective genes |
| 07/28/2005 | WO2005027828A3 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 07/12/2005 | CA2298142C Soya extract, process for its preparation and pharmaceutical composition |
| 06/08/2005 | EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition |
| 06/01/2005 | CN1622754A Novel immune effect compound |
| 03/31/2005 | WO2005027828A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 03/16/2005 | CN1596312A Antibiotics GE 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
| 02/17/2005 | WO2004092329A3 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| 02/10/2005 | WO2005012242A2 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 02/10/2005 | US20050032712 Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides |
| 02/10/2005 | CA2549022A1 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 01/27/2005 | US20050020514 From fermentation of Streptomyces; bactericides |
| 12/08/2004 | EP1482795A1 New immunoeffector compounds |
| 12/07/2004 | CA2287736C Furopyridine antibacterials |
| 12/02/2004 | US20040242502 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for DNA and RNA vaccines |
| 10/28/2004 | WO2004092329A2 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| 10/28/2004 | CA2522213A1 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| 09/23/2004 | US20040186063 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 08/25/2004 | EP1448784A1 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/30/2004 | CN1155620C Thioether conjugates |
| 05/27/2004 | US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer |
| 04/06/2004 | CA2087286C Thioether conjugates |
| 02/12/2004 | WO2003004677A9 Methods for generating differential profiles by combining data obtained in separate measurements |
| 02/10/2004 | US6691042 Methods for generating differential profiles by combining data obtained in separate measurements |
| 10/21/2003 | US6635245 Strain of bacillus for controlling plant diseases |
| 08/19/2003 | US6607757 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 08/14/2003 | WO2003065806A1 New immunoeffector compounds |
| 08/14/2003 | CA2474398A1 New immunoeffector compounds |
| 07/24/2003 | US20030138406 Novel lactobacillus paracasei subsp. paracasei strain antibacterial against helicobacter pyroli and escherichia coli 0157:h7 |
| 06/05/2003 | WO2003046192A1 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/05/2003 | CA2468400A1 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
| 04/24/2003 | US20030078736 Methods for generating differential profiles by combining data obtained in separate measurements |
| 03/26/2003 | CN1406274A Novel lactobacillus paracasei subsp. paracasei strain antibacterial against nelicobacter pylori and escherichia coli 157:H7 |
| 03/20/2003 | WO2003004677A3 Methods for generating differential profiles by combining data obtained in separate measurements |
| 01/16/2003 | WO2003004677A2 Methods for generating differential profiles by combining data obtained in separate measurements |
| 11/12/2002 | CA2077102C Antibiotic ge 2270 factor c2a |
| 11/05/2002 | US6475992 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 08/21/2002 | CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn. |
| 08/14/2002 | EP0748335B1 Antibiotic stalobacins |
| 07/11/2002 | WO2002053706A1 Novel lactobacillus paracasei subsp. paracasei strain antibacterial against helicobacter pylori and escherichia coli 157:h7 |
| 06/12/2002 | EP1007059A4 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 05/29/2002 | CN1351652A Strain of i(bacillus) pumilus for controlling plant diseases |
| 05/16/2002 | US20020058062 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 04/25/2002 | US20020049171 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 01/02/2002 | EP1165751A1 A strain of bacillus pumilus for controlling plant diseases |
| 11/13/2001 | US6316194 Methods and kits for discovery of RNA-binding antimicrobials |
| 08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
| 07/03/2001 | CA2009508C Pf 1022 substance, method of producing same and anthelmintic composition containing same |